国产成人精品久久亚洲高清,精品爱久久久久,精品久久久日本综合电影,超碰人人操天天干,日韩成人一区二区三区在线观看,亚洲精品美女久久久久99,99久久精品免费国产一区,久久婷婷综合国产色啪,久久国产精品中文字幕

Mitral regurgitation (MR) is a common cardiac valve lesion, developing from primary lesions of the mitral valve or secondary to cardiomyopathies. Moderate or higher severity of mitral regurgitation imposes significant volume overload on the left ventricle, causing permanent structural and functional deterioration of the myocardium and heart failure. Since correction of mitral regurgitation can provide symptomatic relief and halt progressive cardiac dysfunction, transcatheter mitral valve repair technologies are emerging as alternative therapies.

Enlight medical is developing transcatheter mitral valve repair and replacement devices, and its repair device NovoClasp^TM is now in the pivotal clinical study in China.